Module

Translating Lessons Learned with HIV Resistance Assays Into Tools for Hepatitis B Virus Resistance Treatment

Source: Clinical Strategies for Preventing and Managing Resistance to Anti-HBV Agents

Translating Lessons Learned with HIV Resistance Assays Into Tools for Hepatitis B Virus Resistance Treatment


Faculty:

  • Angelos Hatzakis, MD

CME CREDIT INFORMATION

Release Date: 04/14/06

Expiration Date: 04/13/07


Physicians: maximum of 1.0 AMA PRA Category 1 Credit(s)™

Status: Please log in to view status


Learning Objectives

Upon completion of this activity, participants should be able to:

  • Review HIV virologic resistance assays that could be used in the treatment of chronic hepatitis B
  • Explain how knowledge gained from HIV phenotyping assays might be applied in the chronic hepatitis B setting
  • Discuss HIV drug resistance testing recommendations in the United States and Europe

Topics covered include:

  • Introduction
  • Virologic Resistance Assays
  • Replication Capacity/Viral Fitness
  • Recommendations for Drug Resistance Testing
  • Conclusion
Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.

Educational grant provided by:

Educational grants support only the CME-certified components of this program.